Who is affected by this change?

This affects Independence Blue Cross Rheumatology, Oncology providers on Commercial plans.

When does this change take effect?

This change is effective Sep 3, 2025.

Back to dashboard

CommercialCoverageMedium impact

08.00.62q, Abatacept (Orencia®) for Injection for Intravenous Use

Independence Blue Cross·Rheumatology, Oncology·Pharmacy

Effective date

Sep 3, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

The Abatacept (Orencia®) for injection policy has been reissued with an effective date of September 3, 2025. This is a pharmacy policy update for commercial plans, though specific changes are not detailed in the summary provided.

Action Required

Action needed

By September 3, 2025: Review the full policy details at the provided URL to understand specific changes to Abatacept coverage requirements. Update billing procedures and prior authorization workflows as needed once full policy details are available.

Related policy hubs

Independence Blue Cross policies Rheumatology Oncology